Skip to main content
Premium Trial:

Request an Annual Quote

Anthem BCBS Georgia, Virginia to Cover Exact Sciences' Cologuard Test

NEW YORK (GenomeWeb) – Anthem Blue Cross Blue Shield (BCBS) of Georgia and Virginia will cover Exact Sciences' Cologuard colorectal cancer screening test as an in-network service for its members, Exact announced today.

Both insurers are the largest commercials providers in their states and part of the second-largest commercial insurance network in the US, Exact added.

"Cologuard's in-network coverage continues to grow this year," said Chairman and CEO Kevin Conroy in a statement. "Together with our recent agreement with Anthem in California, these new contracts ensure Cologuard will be covered as an in-network benefit for nearly half of the insurer's members."

In a recent call where he discussed Exact's Q4 earnings with analysts, Conroy said the agreement with Anthem BCBS in Georgia and Virginia was part of Exact's strategy to get coverage for Cologuard to as many people in the US as possible. The company is in further talks with Anthem to extend coverage for the test for all its members in all states in the first half of 2016. Eventually, Conroy added on the call, he expects Cologuard to be covered by all insurers in the US, though this will take a great deal of time.

The Scan

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.

Lupus Heterogeneity Highlighted With Single-Cell Transcriptomes

Using single-cell RNA sequencing, researchers in Nature Communications tracked down immune and non-immune cell differences between discoid lupus erythematosus and systemic lupus erythematosus.

Rare Disease Clues Gleaned From Mobile Element Insertions in Exome Sequences

With an approach called MELT, researchers in the European Journal of Human Genetics uncovered mobile element insertions in exomes from 3,232 individuals with or without developmental or neurological abnormalities.

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.